|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
2.310 +0.030 (+1.316%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 18,121,861 | 26.689% | 14,304,242 | 19,052,802 | 14,806,168 | 14,320,949 |
| Cost of Sales | (8,847,369) | 24.509% | (7,105,790) | (7,223,639) | (5,680,093) | (5,745,161) |
| Gross Profit | 9,274,492 | 28.840% | 7,198,452 | 11,829,163 | 9,126,075 | 8,575,788 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,366) | -7.019% | (10,073) | (13,879) | (53,725) | (18,009) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (3,699) | 6.324% | (3,479) | (10,749) | (15,874) | (5,051) | |
| Profit / (Loss) before Taxation | 1,224,533 | 45.759% | 840,109 | 2,520,280 | 2,230,091 | 2,154,618 | |
| Taxation | 171,537 | -- | (119,144) | (396,856) | (369,447) | (381,321) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (110,870) | -- | 43,521 | (190,566) | (197,389) | (185,183) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,285,200 | 68.113% | 764,486 | 1,932,858 | 1,663,255 | 1,588,114 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 133,788 | -12.800% | 153,426 | 159,453 | 197,066 | 249,796 |
| Depreciation & Amortisation | 1,133,271 | 3.081% | 1,099,397 | 849,597 | 684,079 | 170,269 |
| Directors' Emoluments | 8,932 | -0.435% | 8,971 | 8,003 | 8,515 | 8,273 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 25.520 | 68.116% | 15.180 | 38.380 | 33.030 | 31.540 |
| DPS (cts) | 0.000 | -- | 4.550 | 11.520 | 0.000 | 9.460 |
| Dividend Payout Ratio (%) | -- | -- | 29.974% | 30.016% | -- | 29.994% |
| Cash flow per share ($) | 0.232 | -- | 0.217 | 0.158 | 0.045 | 0.315 |
| NBV per share ($) | 4.202 | -- | 4.005 | 3.916 | 3.587 | 3.301 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 210,979 |
| %Change | -63.545% |
| EPS / (LPS) | RMB 0.042 |
| NBV Per Share (¥) | RMB 4.244 |